Abstract:Background Portal vein tumour thrombus (PVTT) in patients with hepatocellular carcinoma (HCC) is known as a major complication associated with poor survival. We clinically defined a new and rare type of HCC, PVTT-type HCC (PVTT-HCC), in a small group of HCC patients with HCC presenting only as PVTT without a demonstrable parenchyma tumour. The clinicopathological and biological features of PVTT-HCC are not clear. Methods The data for patients who had PVTT-HCC with histologically confirmed HCC from January 2004 to December 2012 at the Eastern Hepatobiliary Surgery Hospital were retrospectively analysed. The survival outcomes of patients with PVTT-HCC were compared with those of HCC patients with PVTT (HCC-PVTT). Propensity score matching (PSM) analysis was performed to match patients at a ratio of 1:3. Then, we performed RNA-Seq analysis of liver samples from PVTT-HCC and HCC-PVTT patients to identify and compare differentially expressed genes and biological pathways between the two groups. Results We observed and collected 10 rare cases of PVTT-HCC and performed a prospective cohort study to compare overall survival (OS) between PVTT-HCC and HCC-PVTT. PVTT invaded the main portal vein in 10 PVTT-HCC patients. Univariate and multivariate analyses demonstrated that ChildPugh (A/B), different treatments (LR/non-LR), and different groups were independent risk factors for OS. The median OS was 10.3 months (95% CI = 6.7-13.8) in the HCC-PVTT group and 7.5 months (95% CI = 2.8-12.1) in the PVTT-HCC group (P = 0.042). From RNA-Seq, 1,630 differentially expressed genes were obtained, of which 731 were upregulated and 899 downregulated in PVTT-HCC compared with HCC-PVTT. Conclusions The survival outcomes of patients with PVTT-HCC were worse than those of patients with HCC-PVTT. RNA-Seq demonstrated differential gene expression between PVTT-HCC and HCC-PVTT, indicating that the former may have distinguishing biological characteristics and be a new and rare type of HCC.

[Proteomic Analysis on Portal Vein Tumor Thrombus-Associated Proteins for Hepatocellular Carcinoma].

Identification Of Two Portal Vein Tumor Thrombosis Associated Proteins In Hepatocellular Carcinoma: Protein Disulfide-Isomerase A6 And Apolipoprotein A-I

[Study of Serum Proteome Biomarkers with Relation to the Formation of Portal Vein Tumor Thrombi in Hepatocellular Carcinoma Patients].

Comparative Proteome Analysis of PVTT Related Small Molecules

[Screening Low Molecular Weight Protein Biomarkers Relevant to Portal Vein Tumor Thrombi in Serum of Patients with Hepatocellular Carcinoma].

Purification and identification of serum protein biomarkers with relation to portal vein tumor thrombi screened by SELDI-TOF MS

The Potential of Plasma Thrombomodulin As a Biomarker of Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Prognostic Analysis for Treatment Modalities in Hepatocellular Carcinomas with Portal Vein Tumor Thrombi.

Proteomic Analysis of Hepatitis B Virus-Associated Hepatocellular Carcinoma: Identification of Potential Tumor Markers

The Expression of Angiogenic Factors PD-ECGF Mrna and VEGF Mrna in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Identification of prognostic biomarkers associated with the occurrence of portal vein tumor thrombus in hepatocellular carcinoma

Expression of Platelet-Derived Endothelial Cell Growth Factor and Vascular Endothelial Growth Factor in Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

Proteomic Identification of Tumor Biomarkers Associated with Primary Gallbladder Cancer

Proteomic Analysis on Metastasis-Associated Proteins of Human Hepatocellular Carcinoma Tissues

Proteomic and Phosphor-Proteomic Signatures of Clinical Hepatitis B Virus-Associated Hepatocellular Carcinoma

Progress on the molecular mechanism of portal vein tumor thrombosis formation in hepatocellular carcinoma

[Clinical Related Factors of Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma: a Logistic Regression Analysis].

Expression of CD44 and E-CD Protein of Primary Hepatocellular Carcinoma Changed in Portal Vein Tumor Thrombosis

Hepatocellular Carcinoma Associated with Tumor Thrombosis in the Portal Vein: the Effects of Different Treatments.

Correlation Between the Expression of P-gp and Efficacy of Chemotherapy Postoperation in Hepatocellular Carcinoma Patients with Tumor Thrombi in Major Portal Vein

A new and rare type of hepatocellular carcinoma: survival and gene analysis of portal vein tumour thrombus-type hepatocellular carcinoma